Morepen Laboratories Limited

Morepen Labs Q4 Net Profit Rises 69 percent; CDMO Program Moves into Commercial Execution Morepen Labs Q4 FY2026 Financial Results

Morepen Labs Q4 FY2026 Financial Results

Morepen Labs Q4 Net Profit Rises 69 percent; CDMO Program Moves into Commercial Execution

newsyweb.com May 27, 2026

Gurugram, Haryana, India: Morepen Laboratories Limited reported strong Q4 FY26 performance with net profit rising 69% YoY...

Morepen Labs’ Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time Morepen Successfully Clears Fourth Consecutive USFDA Inspection for its Masulkhana Facility with NIL 483 Observation

Morepen Successfully Clears Fourth Consecutive USFDA Inspection for its Masulkhana Facility with NIL 483 Observation

Morepen Labs’ Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time

newsyweb.com April 20, 2026

Gurugram, Haryana, India: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has announced the successful completion of a USFDA...

Morepen Bags Rs. 825 Crore Global Deal

Morepen Bags Rs. 825 Crore Global Deal, Expands into High-Growth CDMO Segment

Morepen Bags Rs. 825 Crore Global Deal

newsyweb.com February 23, 2026

Gurugram, Haryana, India: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has secured a multi-year Contract Development and...